North Carolina Biotechnology Center News Articles

Gov. Jim Hunt, advocate for biotech, dies

ccapot — Fri, 19 Dec 2025 21:16:47 +0000

Gov. Jim Hunt, advocate for biotech, dies ccapot Fri, 12/19/2025 - 16:16 December 19, 2025

James B. Hunt Jr., a populist four-term governor who championed biotechnology as a new economic engine for North Carolina and led the creation of the North Carolina Biotechnology Center, died Dec. 18. He was 88.

“I can think of no one who shaped North Carolina’s recent successes as much as Gov. Jim Hunt,” said Gov. Josh Stein. “He was a visionary who founded Smart Start, raised teacher pay, protected air quality and created the NC Biotech Center. On a personal level, he was a mentor and dear friend.”

Read more about Gov. Jim Hunt, advocate for biotech, dies

Meiogenix relocates US headquarters to RTP to advance precision crop breeding

ccapot — Tue, 25 Nov 2025 15:36:42 +0000

Meiogenix relocates US headquarters to RTP to advance precision crop breeding ccapot Tue, 11/25/2025 - 10:36 December 18, 2025

Meiogenix, a biotechnology company harnessing targeted recombination for precision plant breeding, has relocated its U.S. headquarters to Research Triangle Park from Ithaca, New York.

“Plant breeders are the true pioneers in agriculture, and being here in Research Triangle Park feels like opening a door to limitless innovation,” said Ricardo Garcia de Alba, CEO of Meiogenix. “We’re energized by the chance to collaborate with this exceptional community, bringing fresh ideas and transformational technologies to breeders who are shaping the future of food.”

Read more about Meiogenix relocates US headquarters to RTP to advance precision crop breeding

First patient treated in Toronto hospital for Bantam clinical trial

ccapot — Wed, 17 Dec 2025 20:45:46 +0000

First patient treated in Toronto hospital for Bantam clinical trial ccapot Wed, 12/17/2025 - 15:45 December 17, 2025 Bantam Pharmaceutical, a clinical-stage company pioneering mitochondrial biology to develop first-in-class medicines for treating aggressive cancers, announced that the first patient was treated at The Princess Margaret Cancer Centre in Toronto, Canada, in its Phase 1 clinical trial studying BTM-3566.

Read more about First patient treated in Toronto hospital for Bantam clinical trial

Second Annual CRO Summit addresses cost, complexity and collaboration in clinical trials

ccapot — Tue, 16 Dec 2025 20:19:33 +0000

Second Annual CRO Summit addresses cost, complexity and collaboration in clinical trials ccapot Tue, 12/16/2025 - 15:19 December 16, 2025

Innovative approaches to making clinical studies more efficient and cost-effective were a central theme of the 2nd Annual COG: CRO Summit, held in early December in Durham, N.C. The event convened leaders from clinical research organizations (CROs) and functional service providers for two days of networking and open discussion on the future of the industry.

Read more about Second Annual CRO Summit addresses cost, complexity and collaboration in clinical trials

Novartis breaks ground for RTP expansion

ccapot — Mon, 15 Dec 2025 15:55:55 +0000

Novartis breaks ground for RTP expansion ccapot Mon, 12/15/2025 - 10:55 December 15, 2025 North Carolina Gov. Josh Stein joined state and local officials and life sciences partners to help Novartis break ground on its plans to expand its pharmaceutical manufacturing facilities in the Research Triangle.

Read more about Novartis breaks ground for RTP expansion

Mucommune wins federal funding to develop novel CAR-T cancer therapy

jkennedy — Fri, 05 Dec 2025 17:58:42 +0000

Mucommune wins federal funding to develop novel CAR-T cancer therapy jkennedy Fri, 12/05/2025 - 12:58 December 10, 2025

Mucommune, a Morrisville-based biotechnology company with roots at the University of North Carolina at Chapel Hill, has been awarded up to $29.4 million in federal funding over six years to research and develop a novel cancer therapy.

Read more about Mucommune wins federal funding to develop novel CAR-T cancer therapy

First 3D-bioprinted corneal transplant marks early milestone for Triad’s Precise Bio

ccapot — Mon, 08 Dec 2025 19:14:40 +0000

First 3D-bioprinted corneal transplant marks early milestone for Triad’s Precise Bio ccapot Mon, 12/08/2025 - 14:14 December 8, 2025

Precise Bio Inc., a Greensboro-based clinical-stage regenerative medicine company, has announced the world’s first transplant of a cell-based, functional, 3D-bioprinted cornea. The procedure took place Oct. 29 at Rambam Medical Center in Haifa, Israel, as part of the company’s ongoing Phase I clinical trial.

Read more about First 3D-bioprinted corneal transplant marks early milestone for Triad’s Precise Bio

NCBiotech supports proposed legislation to strengthen US biomanufacturing

ccapot — Tue, 02 Dec 2025 20:50:43 +0000

NCBiotech supports proposed legislation to strengthen US biomanufacturing ccapot Tue, 12/02/2025 - 15:50 December 4, 2025 New legislation proposed by a bipartisan and bicameral group of Congressional legislators and supported by the North Carolina Biotechnology Center would establish a dedicated national center aimed at strengthening U.S. innovation, capacity and workforce for biopharmaceutical manufacturing.

Read more about NCBiotech supports proposed legislation to strengthen US biomanufacturing

Partnerships help Innatrix develop eco-friendly and durable crop protection products

ccapot — Tue, 02 Dec 2025 17:21:10 +0000

Partnerships help Innatrix develop eco-friendly and durable crop protection products ccapot Tue, 12/02/2025 - 12:21 December 2, 2025 Innatrix, an agricultural biotech startup based in RTP, is addressing one of agriculture’s biggest challenges — pathogen and pest resistance to conventional pesticides.

Read more about Partnerships help Innatrix develop eco-friendly and durable crop protection products

Liquidia breaks ground for manufacturing facility at Pathway Triangle

ccapot — Tue, 25 Nov 2025 21:20:33 +0000

Liquidia breaks ground for manufacturing facility at Pathway Triangle ccapot Tue, 11/25/2025 - 16:20 November 25, 2025

Liquidia officials were joined by Pathway Triangle leaders for a groundbreaking ceremony for the company’s new manufacturing facility at 1000 Science Drive in Morrisville.

Read more about Liquidia breaks ground for manufacturing facility at Pathway Triangle